Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis

BACKGROUND: The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is complicated by the variable clinical course. We examined the variability in the rate of disease progression and evaluated the effect of continued treatment with pirfenidone in patients who experienced meaningf...

Descripción completa

Detalles Bibliográficos
Autores principales: Nathan, Steven D, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, du Bois, Roland M, Fagan, Elizabeth A, Fishman, Robert S, Glaspole, Ian, Glassberg, Marilyn K, Glasscock, Kenneth F, King, Talmadge E, Lancaster, Lisa, Lederer, David J, Lin, Zhengning, Pereira, Carlos A, Swigris, Jeffrey J, Valeyre, Dominique, Noble, Paul W, Wells, Athol U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Interstitial Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862066/
https://www.ncbi.nlm.nih.gov/pubmed/26968970
http://dx.doi.org/10.1136/thoraxjnl-2015-207011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862066/
https://www.ncbi.nlm.nih.gov/pubmed/26968970
http://dx.doi.org/10.1136/thoraxjnl-2015-207011

Ejemplares similares